Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 1.9 million during the last session, with the company’s beta value hitting -0.89. At the close of
In the latest trading session, 0.64 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -0.88. With the company’s most recent
In last trading session, Summit Therapeutics Inc (NASDAQ:SMMT) saw 2.28 million shares changing hands with its beta currently measuring -0.90. Company’s recent per share price
Summit Therapeutics Inc (NASDAQ:SMMT) has a beta value of -0.92 and has seen 2.3 million shares traded in the last trading session. The company, currently
During the last session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 2.28 million, with the beta value of the company hitting -0.96. At the end
In the last trading session, 2.31 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -0.96. Most recently the company’s
In the last trading session, 2.72 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -0.96. Most recently the company’s
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 1.41 million during the last session, with the company’s beta value hitting -0.96. At the close of
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 2.1 million during the last session, with the company’s beta value hitting -0.97. At the close of
In the last trading session, 2.16 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -0.97. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
